Evidence map›Paper›PMID 32763829›Full record

ArticleEBioMedicine2020

Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study.

Rebeca Eriksen, Isabel Garcia Perez, Joram M Posma, Mark Haid, Sapna Sharma, Cornelia Prehn, Louise E Thomas, Robert W Koivula, Roberto Bizzotto, Cornelia Prehn and 28 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 19 institutions in 9 countries.

Rebeca EriksenSection for Nutrition Research, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, United Kingdom. Electronic address: r.eriksen13@imperial.ac.uk.
Isabel Garcia PerezSection for Nutrition Research, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, United Kingdom.
Joram M PosmaSection of Bioinformatics, Division of Systems Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College, London, United Kingdom; Health Data Research UK, London, United Kingdom.
Mark HaidResearch Unit Molecular Endocrinology And Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environemental Health (GmbH), Neuherberg, Germany.
Sapna SharmaGerman Center for Diabetes Research (DZD), Ingolstädter Landstr. 1, 85764 Neuherberg, Germany; Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Bavaria, Germany.
Cornelia PrehnResearch Unit Molecular Endocrinology And Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environemental Health (GmbH), Neuherberg, Germany.
Louise E ThomasResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Robert W KoivulaGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom.
Roberto BizzottoInstitute of Neuroscience - National Research Council, Padova, Italy.
Cornelia PrehnResearch Unit Molecular Endocrinology And Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environemental Health (GmbH), Neuherberg, Germany.
Andrea MariInstitute of Neuroscience - National Research Council, Padova, Italy.
Giuseppe N GiordanoGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Imre PavoEli Lilly Regional Operations GmbH, Vienna, Austria.
Jochen M SchwenkScience for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH - Royal Institute of Technology, Stockholm, Sweden.
Federico De MasiDepartment of Health Technology, Technical University of Denmark, Kgs Lyngby and The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Konstantinos D TsirigosDepartment of Health Technology, Technical University of Denmark, Kgs Lyngby and The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Søren BrunakDepartment of Health Technology, Technical University of Denmark, Kgs Lyngby and The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark; Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, DK-2200 Copenhagen, Denmark.
Ana ViñuelaDepartment of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Anubha MahajanWellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Timothy J McDonaldMedical School, Exeter, UK NIHR Exeter Clinical Research Facility, University of Exeter.
Tarja KokkolaDepartment of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
Femke RutterDepartment of Epidemiology and Biostatistics, Amsterdam Public Health Institute, Amsterdam UMC, locationVUMC, Amsterdam, Netherlands.
Harriet TeareWellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Tue H HansenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
Juan FernandezWellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Angus JonesMedical School, Exeter, UK NIHR Exeter Clinical Research Facility, University of Exeter.
Chris JennisonDepartment of Mathematical Sciences, University of Bath, Bath, United Kingdom.
Mark WalkerInstitute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, United Kingdom.
Mark I McCarthyOxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Department of Medicine, Oxford, United Kingdom; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
Oluf PedersenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.
Hartmut RuettenSanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.
Ian ForgiePopulation Health & Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Jimmy D BellResearch Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.
Ewan R PearsonPopulation Health & Genomics, School of Medicine, University of Dundee, Dundee, United Kingdom.
Paul W FranksGenetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Jerzy AdamskiResearch Unit Molecular Endocrinology And Metabolism, Helmholtz Zentrum Muenchen, German Research Center for Environemental Health (GmbH), Neuherberg, Germany; Lehrstuhl für Experimentelle Genetik, Technische Universität München, 85350 Freising-Weihenstephan, Germany; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, Singapore 117597, Singapore.
Elaine HolmesSection for Nutrition Research, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, United Kingdom.
Gary FrostSection for Nutrition Research, Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, United Kingdom; NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom. Electronic address: g.frost@imperial.ac.uk.
University of Copenhagen · DKCentre for Human Genetics · GBHelmholtz Zentrum München · DEImperial College London · GBLund University · SENational Research Council · ITUniversity of Dundee · GBUniversity of Exeter · GBUniversity of Westminster · GBAmsterdam University Medical Centers · NLChurchill Hospital · GBHealth Data Research UK · GBNational University of Singapore · SGNewcastle University · GBSanofi (Germany) · DEScience for Life Laboratory · SEUniversity of Bath · GBUniversity of Eastern Finland · FIUniversity of Geneva · CH

Funding

Integrating genome-scale data to reveal causal mechanisms in type 2 diabetesU01DK105535 · NIDDK · UNIVERSITY OF OXFORD · PI GLOYN, ANNA LOUISE · 2015 to 2019
$1.7M
Department of Health CDF-2017-10-032Department of Health PDF-2012-05-456Medical Research Council MR/S004033/1NIDDK NIH HHS U01 DK105535Wellcome Trust 102820/Z/13/Z
6 · The paper itself

Abstract

backgroundDietary advice remains the cornerstone of prevention and management of type 2 diabetes (T2D). However, understanding the efficacy of dietary interventions is confounded by the challenges inherent in assessing free living diet. Here we profiled dietary metabolites to investigate glycaemic deterioration and cardiometabolic risk in people at risk of or living with T2D.

methodsWe analysed data from plasma collected at baseline and 18-month follow-up in individuals from the Innovative Medicines Initiative (IMI) Diabetes Research on Patient Stratification (DIRECT) cohort 1 n = 403 individuals with normal or impaired glucose regulation (prediabetic) and cohort 2 n = 458 individuals with new onset of T2D. A dietary metabolite profile model (T

findingsA higher T

interpretationPlasma dietary metabolite profiling provides objective measures of diet intake, showing a relationship to glycaemic deterioration and cardiometabolic health.

fundingThis work was supported by the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115,317 (DIRECT), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies.

Indexed as

AgedCase-Control StudiesCholesterol, HDLDiabetes Mellitus, Type 2Diet, HealthyEnergy IntakeFemaleHumansMaleMetabolomicsMiddle AgedPrediabetic StateTriglyceridesCholesterol, HDLTriglyceridesCardiometabolic healthDietary patternsMetabolic profilingType 2 diabetes

Identifiers

PMID32763829
PMCPMC7406914
OpenAlexW3047507531

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.